Rock Springs Capital Management LP Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$1.7T
Holdings
140
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (140 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —CARDIOME PHARMA CORP | 1,200,000 | $3.6B | 0.21% | |
| 102 | CGENCOMPUGEN LTD | 825,000 | $3.5B | 0.20% | |
| 103 | —PROTEOSTASIS THERAPEUTICS IN | 450,000 | $3.5B | 0.20% | |
| 104 | PBYIPUMA BIOTECHNOLOGY INC | 94,500 | $3.5B | 0.20% | |
| 105 | MDGLMADRIGAL PHARMACEUTICALS INC | 225,000 | $3.5B | 0.20% | |
| 106 | RIGLUSDRIGEL PHARMACEUTICALS INC | 1,000,000 | $3.3B | 0.19% | |
| 107 | INVAINNOVIVA INC | 235,000 | $3.3B | 0.19% | |
| 108 | GKOSGLAUKOS CORP | 62,500 | $3.2B | 0.18% | |
| 109 | HRCHILL ROM HLDGS INC | 45,000 | $3.2B | 0.18% | |
| 110 | ITCIEURINTRA CELLULAR THERAPIES INC | 190,000 | $3.1B | 0.18% | |
| 111 | —GENOCEA BIOSCIENCES INC | 480,000 | $2.9B | 0.17% | |
| 112 | —BLUEBIRD BIO INC | 30,500 | $2.8B | 0.16% | |
| 113 | CARAEURCARA THERAPEUTICS INC | 150,000 | $2.8B | 0.16% | |
| 114 | ZBHZIMMER BIOMET HLDGS INC | 21,100 | $2.6B | 0.15% | |
| 115 | OTICEUROTONOMY INC | 210,000 | $2.6B | 0.15% | |
| 116 | —DBV TECHNOLOGIES S A | 73,000 | $2.6B | 0.15% | |
| 117 | MCRB1EURSERES THERAPEUTICS INC | 220,000 | $2.5B | 0.14% | |
| 118 | —CIDARA THERAPEUTICS INC | 300,000 | $2.3B | 0.14% | |
| 119 | —NEURODERM LTD | 84,079 | $2.2B | 0.13% | |
| 120 | HQYHEALTHEQUITY INC | 50,000 | $2.1B | 0.12% | |
| 121 | SCYXEURSCYNEXIS INC | 760,000 | $2.1B | 0.12% | |
| 122 | —THERAVANCE BIOPHARMA INC | 1,500,000 | $1.9B | 0.11% | |
| 123 | —MYOVANT SCIENCES LTD | 150,000 | $1.8B | 0.10% | |
| 124 | —NIVALIS THERAPEUTICS INC | 600,000 | $1.8B | 0.10% | |
| 125 | NVCRNOVOCURE LTD | 214,316 | $1.7B | 0.10% | |
| 126 | —ATYR PHARMA INC | 475,000 | $1.7B | 0.10% | |
| 127 | —NEWLINK GENETICS CORP | 67,071 | $1.6B | 0.09% | |
| 128 | —EGALET CORP | 300,000 | $1.5B | 0.09% | |
| 129 | —WRIGHT MED GROUP INC | 1,000,000 | $1.2B | 0.07% | |
| 130 | NVAXNOVAVAX INC | 820,000 | $1.1B | 0.06% | |
| 131 | PRGOPERRIGO CO PLC | 15,600 | $1.0B | 0.06% | |
| 132 | DVAXDYNAVAX TECHNOLOGIES CORP | 165,000 | $982.0M | 0.06% | |
| 133 | INFIQINFINITY PHARMACEUTICALS INC | 270,000 | $872.0M | 0.05% | |
| 134 | —CHIASMA INC | 492,500 | $837.0M | 0.05% | |
| 135 | BHCVALEANT PHARMACEUTICALS INTL | 66,400 | $732.0M | 0.04% | |
| 136 | —TANDEM DIABETES CARE INC | 595,000 | $714.0M | 0.04% | |
| 137 | —OREXIGEN THERAPEUTICS INC | 165,300 | $569.0M | 0.03% | |
| 138 | —ANTHERA PHARMACEUTICALS INC | 1,296,568 | $552.0M | 0.03% | |
| 139 | —CERULEAN PHARMA INC | 625,000 | $508.0M | 0.03% | |
| 140 | —DIMENSION THERAPEUTICS INC | 271,370 | $475.0M | 0.03% |
PreviousPage 2 of 2